Ferrata Storti Foundation
Meet Three Women in Science Championing Myeloma Cures and Care | Leukemia and Lymphoma Society
DISSECTING THE MECHANISMS OF VENETOCLAX RESISTANCE IN MYELODYSPLASTIC SYNDROMES
Hematopoiesis under telomere attrition at the single-cell resolution | Nature Communications
Daiana Grimaldi, PhD - Project Manager - Università degli studi di Parma | LinkedIn
Simona Colla | Leukemia and Lymphoma Society
Ferrata Storti Foundation
Who We Fund | Leukemia and Lymphoma Society
Peter WT Pisters, MD on Twitter: "Enjoyed celebrating @MDAndersonNews' Rogers Award for Excellence in Research recipient Padmanee Sharma and finalists Simona Colla, Vanessa Jensen, Sattva Neelapu and Nakia Spencer. Their excellent research
Peter WT Pisters, MD on Twitter: "Enjoyed celebrating @MDAndersonNews' Rogers Award for Excellence in Research recipient Padmanee Sharma and finalists Simona Colla, Vanessa Jensen, Sattva Neelapu and Nakia Spencer. Their excellent research
Update on the pathogenesis of osteolysis in multiple myeloma patients
Telomere Dysfunction Drives Aberrant Hematopoietic Differentiation and Myelodysplastic Syndrome
Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood …
Myelodysplastic syndrome (MDS) researcher: Leaps of faith led to my career at MD Anderson | MD Anderson Cancer Center
Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 re
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetocl — JRNLclub, the online journal club
Simona Colla, dall'ateneo di Parma al centro di ricerca sul cancro in Texas: "Il mio viaggio nella scienza" - la Repubblica
Break Through Cancer funds AML research at MD Anderson
Breakthrough Cancer awards MD Anderson $5.7M for AML research | Mirage News
Meet Three Women in Science Championing Myeloma Cures and Care | Leukemia and Lymphoma Society
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy | Nature Medicine
STAT3 protects HSCs from intrinsic interferon signaling and loss of long-term blood-forming activity
Angiopoietin-1 and Myeloma-Induced Angiogenesis
Simona Colla | MD Anderson Cancer Center
Simona Colla, Ph.D., Universit [IMAGE] | EurekAlert! Science News Releases
Simona Colla | MD Anderson Cancer Center
